People: Accuray Inc (ARAY.O)

ARAY.O on Nasdaq

7.46USD
1:21pm EST
Change (% chg)

$0.07 (+0.95%)
Prev Close
$7.39
Open
$7.28
Day's High
$7.49
Day's Low
$7.27
Volume
804,875
Avg. Vol
882,200
52-wk High
$10.85
52-wk Low
$5.99

Search Stocks

Goldstein, Jack 

Brief Biography

Dr. Jack Goldstein Ph.D. is Independent Director of Accuray Incorporated., since May 25, 2010. Dr. Goldstein has been an independent consultant since 2006 specializing in human medical diagnostics, biopharmaceuticals and medical devices. He served as President and Chief Operating Officer of Chiron Corporation from 2004 until its acquisition by Novartis in 2006, and from 2002 to 2004 he served as President of Chiron's Blood Testing Division. From 2000 to 2002, he was a general partner at Windamere Venture Partners, a private venture capital investment fund. From 1997 to 2001, he served as President and Chief Executive Officer at Applied Imaging Corporation, and from 1999 until 2002, he also served as Chairman of the Board of Applied Imaging. From 1986 to 1997, Dr. Goldstein served in various executive positions at Johnson & Johnson, including President of Ortho Diagnostic Systems and Executive Vice President of Professional Diagnostics. Dr. Goldstein currently serves as Chairman of the Board of Directors of OncoGenex Pharmaceuticals, Inc., a drug discovery and development company. In the past five years, Dr. Goldstein has also served on the following public company boards of directors: Immucor, Inc., Illumina, Inc. and Orasure Technologies, Inc.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Louis Lavigne

--

Joshua Levine

4,783,760

Gregory Lichtwardt

2,343,670

Kelly Londy

1,027,390

Alaleh Nouri

769,772

Jack Goldstein

--
As Of 29 Jun 2014
Search Stocks